Veeva Vault CRM Surpasses 125 Clients in Life Sciences
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 3 hours ago
0mins
Should l Buy VEEV?
Source: PRnewswire
- Significant Client Growth: Veeva Vault CRM has now attracted over 125 clients, including several of the top 20 global biopharmaceutical companies, demonstrating its strong appeal and market demand in the life sciences sector.
- Industry Leadership: The success of Vault CRM, coupled with the launch of Veeva AI, is driving the industry's shift towards intelligent customer relationship management, enhancing customer engagement and business efficiency.
- Support Timeline Adjustment: Veeva has moved the end-of-support date for Veeva CRM from September 2030 to December 2029, indicating the company's strategic focus on Vault CRM and its positioning in the market.
- Comprehensive Solution: Vault CRM serves as the core technology platform for biopharmaceutical companies, encompassing event management, service centers, and patient CRM functionalities, aimed at optimizing customer relationship management and product lifecycle support.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy VEEV?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on VEEV
Wall Street analysts forecast VEEV stock price to rise
23 Analyst Rating
16 Buy
6 Hold
1 Sell
Moderate Buy
Current: 181.450
Low
222.00
Averages
317.10
High
380.00
Current: 181.450
Low
222.00
Averages
317.10
High
380.00
About VEEV
Veeva Systems Inc. is a provider of cloud solutions for the global life sciences industry. It offers span cloud software, data, and business consulting and is designed to meet the needs of its customers and the strategic business functions from research and development (R&D) through commercialization. Its four product categories include Veeva Development Cloud, Veeva Quality Cloud, Veeva Commercial Cloud, and Veeva Data Cloud. Veeva Development Cloud includes application suites for the clinical, regulatory, and safety functions of life sciences companies, all built on its Veeva Vault platform. Veeva Quality Cloud unifies applications, processes, and partners across content management, training, quality management, assurance, and control lab solutions on the Veeva Vault platform. Veeva Commercial Cloud is a product category comprised of software and analytics solutions. Veeva Data Cloud is a data platform comprised of connected reference data, deep data, and transaction data.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Veeva Systems Set to Announce Q4 Earnings on March 4
- Earnings Announcement: Veeva Systems is set to release its Q4 fiscal year 2024 earnings on March 4 after market close, with consensus EPS estimates at $1.94, reflecting an 11.5% year-over-year growth, indicating the company's ongoing growth potential in the biopharmaceutical sector.
- Revenue Expectations: The anticipated revenue for Q4 is $810.95 million, representing a 12.5% year-over-year increase, which suggests strong performance in customer demand and market share, potentially solidifying its leadership position in the industry.
- Performance Beat Record: Over the past two years, Veeva has beaten EPS estimates 88% of the time and revenue estimates 100% of the time, showcasing a consistent performance that enhances investor confidence and may positively impact stock prices.
- Estimate Revision Trends: In the last three months, EPS estimates have seen two upward revisions and no downward adjustments, while revenue estimates have experienced four upward revisions and one downward, indicating a market optimism regarding Veeva's future performance that could attract more investor interest.
See More
Veeva Vault CRM Leads Life Sciences Industry with Over 125 Customers
- Customer Milestone: Veeva Vault CRM is now live with over 125 customers, including multiple top 20 biopharma companies, demonstrating its broad acceptance and application within the life sciences sector.
- Accelerated Industry Transformation: With the introduction of Veeva AI, Vault CRM is accelerating the industry's shift towards agentic customer relationship management, providing deep industry functionality and compliance to help clients optimize complex customer engagements.
- Lifecycle Support: Vault CRM offers the foundational support that commercial and medical teams need to manage the full product lifecycle, from market preparation to optimizing mature brand performance, ensuring effective management of complex customer relationships.
- Infrastructure Upgrade: Veeva has moved the end-of-support date for Veeva CRM from September 2030 to December 2029, reflecting the company's commitment to Vault CRM and customer success, further solidifying its leadership position in the industry.
See More
Veeva Vault CRM Surpasses 125 Clients in Life Sciences
- Significant Client Growth: Veeva Vault CRM has now attracted over 125 clients, including several of the top 20 global biopharmaceutical companies, demonstrating its strong appeal and market demand in the life sciences sector.
- Industry Leadership: The success of Vault CRM, coupled with the launch of Veeva AI, is driving the industry's shift towards intelligent customer relationship management, enhancing customer engagement and business efficiency.
- Support Timeline Adjustment: Veeva has moved the end-of-support date for Veeva CRM from September 2030 to December 2029, indicating the company's strategic focus on Vault CRM and its positioning in the market.
- Comprehensive Solution: Vault CRM serves as the core technology platform for biopharmaceutical companies, encompassing event management, service centers, and patient CRM functionalities, aimed at optimizing customer relationship management and product lifecycle support.
See More
Veeva Vault CRM Surpasses 125 Clients Globally
- Client Base Expansion: Veeva Vault CRM has now attracted over 125 clients, including several of the top 20 global biopharmaceutical companies, demonstrating its strong appeal and market demand in the life sciences sector.
- Accelerated Industry Transformation: With the support of Veeva AI, Vault CRM is accelerating the industry's shift towards agent-driven customer relationship management, enhancing the efficiency and quality of customer interactions, thereby solidifying Veeva's leadership position in the market.
- Product Functionality Advantage: Vault CRM offers comprehensive regional and industry functionalities that ensure compliance and efficient workflows, supporting all stages of the product lifecycle from market preparation to brand optimization, thereby enhancing clients' business capabilities.
- Support End Date Advancement: Veeva has moved the end date for Veeva CRM support from September 2030 to December 2029, reflecting the company's confidence in the success of Vault CRM and encouraging clients to transition to the new system as soon as possible.
See More
Veeva Vault CRM Leads Life Sciences with Over 125 Customers Live
- Customer Milestone: Veeva Vault CRM has successfully onboarded over 125 customers, including multiple top 20 biopharma companies, demonstrating its widespread acceptance and application in the life sciences sector.
- Accelerated Industry Shift: With the introduction of Veeva AI, Vault CRM is accelerating the industry's transition to agentic customer relationship management, enhancing customer engagement and operational efficiency, thereby solidifying Veeva's market leadership.
- Lifecycle Support: Vault CRM provides the foundational support for commercial and medical teams throughout the full product lifecycle, facilitating complex customer interactions from market preparation to optimizing mature brand performance, ensuring sustained business growth and customer satisfaction.
- Infrastructure Upgrade: Veeva has moved the end-of-support date for Veeva CRM from September 2030 to December 2029, indicating a strong commitment to Vault CRM and providing customers with a clear upgrade path to maintain competitiveness.
See More
Major Retailers Continue Earnings Season This Week
- AST SpaceMobile Earnings Outlook: AST SpaceMobile, Inc. (NASDAQ:ASTS) is set to report its Q4 results after Monday's close, with Wall Street anticipating a loss of 16 cents per share on revenue of $41.11 million, indicating competitive pressures in the market.
- CrowdStrike Growth Target: CrowdStrike Holdings, Inc. (NASDAQ:CRWD) will release its earnings after Tuesday's close, with investors keen to see if it can achieve at least 50% year-over-year growth in net new ARR, confirming its 20% growth trajectory and justifying its premium valuation.
- Broadcom Earnings Focus: Broadcom Inc. (NASDAQ:AVGO) is expected to report its Q1 results on Wednesday afternoon, with analysts forecasting EPS of $2.02 on revenue of $19.14 billion, while investors will be watching if AI semiconductor revenue doubles to $8.2 billion.
- JD.com Earnings Preview: JD.com, Inc. (NASDAQ:JD) is expected to release its results before Thursday's open, with Wall Street predicting a loss of 3 cents per share and revenue of $50.22 billion, reflecting the challenges and opportunities in the Chinese e-commerce market.
See More
Veeva Systems Set to Announce Q4 Earnings on March 4
- Earnings Announcement: Veeva Systems is set to release its Q4 fiscal year 2024 earnings on March 4 after market close, with consensus EPS estimates at $1.94, reflecting an 11.5% year-over-year growth, indicating the company's ongoing growth potential in the biopharmaceutical sector.
- Revenue Expectations: The anticipated revenue for Q4 is $810.95 million, representing a 12.5% year-over-year increase, which suggests strong performance in customer demand and market share, potentially solidifying its leadership position in the industry.
- Performance Beat Record: Over the past two years, Veeva has beaten EPS estimates 88% of the time and revenue estimates 100% of the time, showcasing a consistent performance that enhances investor confidence and may positively impact stock prices.
- Estimate Revision Trends: In the last three months, EPS estimates have seen two upward revisions and no downward adjustments, while revenue estimates have experienced four upward revisions and one downward, indicating a market optimism regarding Veeva's future performance that could attract more investor interest.
See More
Veeva Vault CRM Leads Life Sciences Industry with Over 125 Customers
- Customer Milestone: Veeva Vault CRM is now live with over 125 customers, including multiple top 20 biopharma companies, demonstrating its broad acceptance and application within the life sciences sector.
- Accelerated Industry Transformation: With the introduction of Veeva AI, Vault CRM is accelerating the industry's shift towards agentic customer relationship management, providing deep industry functionality and compliance to help clients optimize complex customer engagements.
- Lifecycle Support: Vault CRM offers the foundational support that commercial and medical teams need to manage the full product lifecycle, from market preparation to optimizing mature brand performance, ensuring effective management of complex customer relationships.
- Infrastructure Upgrade: Veeva has moved the end-of-support date for Veeva CRM from September 2030 to December 2029, reflecting the company's commitment to Vault CRM and customer success, further solidifying its leadership position in the industry.
See More
Veeva Vault CRM Surpasses 125 Clients in Life Sciences
- Significant Client Growth: Veeva Vault CRM has now attracted over 125 clients, including several of the top 20 global biopharmaceutical companies, demonstrating its strong appeal and market demand in the life sciences sector.
- Industry Leadership: The success of Vault CRM, coupled with the launch of Veeva AI, is driving the industry's shift towards intelligent customer relationship management, enhancing customer engagement and business efficiency.
- Support Timeline Adjustment: Veeva has moved the end-of-support date for Veeva CRM from September 2030 to December 2029, indicating the company's strategic focus on Vault CRM and its positioning in the market.
- Comprehensive Solution: Vault CRM serves as the core technology platform for biopharmaceutical companies, encompassing event management, service centers, and patient CRM functionalities, aimed at optimizing customer relationship management and product lifecycle support.
See More
Veeva Vault CRM Surpasses 125 Clients Globally
- Client Base Expansion: Veeva Vault CRM has now attracted over 125 clients, including several of the top 20 global biopharmaceutical companies, demonstrating its strong appeal and market demand in the life sciences sector.
- Accelerated Industry Transformation: With the support of Veeva AI, Vault CRM is accelerating the industry's shift towards agent-driven customer relationship management, enhancing the efficiency and quality of customer interactions, thereby solidifying Veeva's leadership position in the market.
- Product Functionality Advantage: Vault CRM offers comprehensive regional and industry functionalities that ensure compliance and efficient workflows, supporting all stages of the product lifecycle from market preparation to brand optimization, thereby enhancing clients' business capabilities.
- Support End Date Advancement: Veeva has moved the end date for Veeva CRM support from September 2030 to December 2029, reflecting the company's confidence in the success of Vault CRM and encouraging clients to transition to the new system as soon as possible.
See More
Veeva Vault CRM Leads Life Sciences with Over 125 Customers Live
- Customer Milestone: Veeva Vault CRM has successfully onboarded over 125 customers, including multiple top 20 biopharma companies, demonstrating its widespread acceptance and application in the life sciences sector.
- Accelerated Industry Shift: With the introduction of Veeva AI, Vault CRM is accelerating the industry's transition to agentic customer relationship management, enhancing customer engagement and operational efficiency, thereby solidifying Veeva's market leadership.
- Lifecycle Support: Vault CRM provides the foundational support for commercial and medical teams throughout the full product lifecycle, facilitating complex customer interactions from market preparation to optimizing mature brand performance, ensuring sustained business growth and customer satisfaction.
- Infrastructure Upgrade: Veeva has moved the end-of-support date for Veeva CRM from September 2030 to December 2029, indicating a strong commitment to Vault CRM and providing customers with a clear upgrade path to maintain competitiveness.
See More
Major Retailers Continue Earnings Season This Week
- AST SpaceMobile Earnings Outlook: AST SpaceMobile, Inc. (NASDAQ:ASTS) is set to report its Q4 results after Monday's close, with Wall Street anticipating a loss of 16 cents per share on revenue of $41.11 million, indicating competitive pressures in the market.
- CrowdStrike Growth Target: CrowdStrike Holdings, Inc. (NASDAQ:CRWD) will release its earnings after Tuesday's close, with investors keen to see if it can achieve at least 50% year-over-year growth in net new ARR, confirming its 20% growth trajectory and justifying its premium valuation.
- Broadcom Earnings Focus: Broadcom Inc. (NASDAQ:AVGO) is expected to report its Q1 results on Wednesday afternoon, with analysts forecasting EPS of $2.02 on revenue of $19.14 billion, while investors will be watching if AI semiconductor revenue doubles to $8.2 billion.
- JD.com Earnings Preview: JD.com, Inc. (NASDAQ:JD) is expected to release its results before Thursday's open, with Wall Street predicting a loss of 3 cents per share and revenue of $50.22 billion, reflecting the challenges and opportunities in the Chinese e-commerce market.
See More
